Jan 6 (Reuters) - Medicure Inc MPH.V :
* Says has initiated the development of a high-value cardiovascular generic
drug
* Project is a collaboration between Medicure International Inc and apicore US
llc
* Co and apicore have entered into an exclusive product supply and development
agreement under which Medicure holds all commercial rights
* Says companies anticipate filing the anda with the U.S. food and drug
administration by the end of 2016
* Source text for Eikon ID:nCNWZx2Xqa
* Further company coverage MPH.V